PAK1 and breast carcinoma: Consistent with previous reports evaluating PAK1 function in breast cancer cell lines via genetic approaches [9], dose-dependent inhibition of PAK1 effector signaling was correlated with poly(ADP-ribose) polymerase (PARP) cleavage.